chrX-49270146-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_033215.5(PPP1R3F):c.277G>A(p.Glu93Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000026 in 1,075,247 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000035 ( 0 hom., 1 hem., cov: 24)
Exomes 𝑓: 0.000025 ( 0 hom. 6 hem. )
Consequence
PPP1R3F
NM_033215.5 missense
NM_033215.5 missense
Scores
3
1
13
Clinical Significance
Conservation
PhyloP100: 1.49
Genes affected
PPP1R3F (HGNC:14944): (protein phosphatase 1 regulatory subunit 3F) This gene encodes a protein that has been identified as one of several type-1 protein phosphatase (PP1) regulatory subunits. One or two of these subunits, together with the well-conserved catalytic subunit, can form the PP1 holoenzyme, where the regulatory subunit functions to regulate substrate specificity and/or targeting to a particular cellular compartment. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.06696558).
BS2
High Hemizygotes in GnomAdExome4 at 6 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPP1R3F | NM_033215.5 | c.277G>A | p.Glu93Lys | missense_variant | 1/4 | ENST00000055335.11 | NP_149992.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPP1R3F | ENST00000055335.11 | c.277G>A | p.Glu93Lys | missense_variant | 1/4 | 2 | NM_033215.5 | ENSP00000055335.6 | ||
ENSG00000290184 | ENST00000703450.1 | c.-224+66C>T | intron_variant | ENSP00000515301.1 |
Frequencies
GnomAD3 genomes AF: 0.0000354 AC: 4AN: 112845Hom.: 0 Cov.: 24 AF XY: 0.0000285 AC XY: 1AN XY: 35111
GnomAD3 genomes
AF:
AC:
4
AN:
112845
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
35111
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000510 AC: 2AN: 39215Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 4873
GnomAD3 exomes
AF:
AC:
2
AN:
39215
Hom.:
AF XY:
AC XY:
0
AN XY:
4873
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000249 AC: 24AN: 962355Hom.: 0 Cov.: 31 AF XY: 0.0000199 AC XY: 6AN XY: 301127
GnomAD4 exome
AF:
AC:
24
AN:
962355
Hom.:
Cov.:
31
AF XY:
AC XY:
6
AN XY:
301127
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000354 AC: 4AN: 112892Hom.: 0 Cov.: 24 AF XY: 0.0000284 AC XY: 1AN XY: 35170
GnomAD4 genome
AF:
AC:
4
AN:
112892
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
35170
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
9
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 29, 2024 | The c.277G>A (p.E93K) alteration is located in exon 1 (coding exon 1) of the PPP1R3F gene. This alteration results from a G to A substitution at nucleotide position 277, causing the glutamic acid (E) at amino acid position 93 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
FATHMM_MKL
Benign
D
LIST_S2
Benign
T
M_CAP
Pathogenic
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
D;D;D;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Pathogenic
D
Polyphen
B
Vest4
MutPred
Gain of ubiquitination at E93 (P = 0.0048);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at